Skip to main content
# Title Department Research Year
51 Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and Topoisomerase IV inhibitors endowed with antibacterial properties Department of Pharmaceutical Organic Chemistry 2024
52 Nanostructured gold-embedded porous carbon black nanoceramic film coating on pencil graphite rods: An innovative disposable ultrasensitive sensor for monitoring dopamine Department of Pharmaceutical Analytical Chemistry 2024
53 Sertaconazole-PLGA nanoparticles for management of ocular keratitis Department of Pharmaceutics 2024
54 Design, synthesis, and antiproliferative activity of new 1,2,3-Triazole/Quinazoline-4-one hybrids as dual EGFR/BRAFV600E inhibitors Department of Pharmaceutical Organic Chemistry 2024
55 Design, synthesis, biological evaluation and docking study of some new aryl and heteroaryl thiomannosides as FimH antagonists Department of Pharmaceutical Organic Chemistry 2024
56 A surfactant-based quasi-hydrophobic deep eutectic solvent for dispersive liquid-liquid microextraction of gliflozins from environmental water samples using UHPLC/fluorescence detection Department of Pharmaceutical Analytical Chemistry 2024
57 New diaryl-1,2,4-triazolo[3,4-a]pyrimidine hybrids as selective COX-2/sEH dual inhibitors with potent analgesic/anti-inflammatory and cardioprotective properties Department of Pharmaceutical Organic Chemistry 2024
58 Dual emission BSA-capped bimetallic nanoclusters for detection of acrylamide in certain food matrices based on thiol-ene Michael addition click reaction Department of Pharmaceutical Analytical Chemistry 2024
59 Evaluating anthelmintic, anti‑platelet, and anti‑coagulant activities, and identifying the bioactive phytochemicals of Amaranthus blitum L. Department of Pharmacognosy 2024
60 Design and synthesis of new 1,2,4-oxadiazole/quinazoline-4-one hybrids with antiproliferative activity as multitargeted inhibitors Department of Pharmaceutical Organic Chemistry 2024